Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2003
09/09/2003US6617112 Methods for gene array analysis of nuclear runoff transcripts
09/09/2003US6617111 Method for measuring unit activity of an enzyme
09/09/2003US6617110 Cultured cell comprising a nucleic acid sequence, encoding the protein, that hybridizes to a polynucleotide of given sequence; use to determine if drug is cytotoxic; can use as anticarcinogenic agent
09/09/2003US6617107 Specific oligonucleotide primers for detection of bovine male chromosome presence by polymerase chain reaction and method
09/09/2003US6617106 Methods for preparing oligonucleotides containing non-standard nucleotides
09/09/2003US6617105 Binding cells in sample onto a solid support, lysing the isolated cells and binding them to another solid support; use in many biochemical and diagnostic procedures
09/09/2003US6617104 Predisposition to breast cancer by mutations at the ataxia-telangiectasia genetic locus
09/09/2003US6617103 Detecting the presence of hybridized nucleic acid; use for diagnosis and treatment of genital cancer
09/09/2003US6617102 Screening for a bioactive agent capable of interfering with the binding of a protein; use in diagnosis and treatment of cancer
09/09/2003US6616824 Apparatus for electrophoresis
09/09/2003US6615791 Modular internal combustion engine
09/09/2003CA2213731C Methods and reagents for typing hla class i genes
09/09/2003CA2142121C Effects of actin filaments on fibrin clot structure and lysis
09/09/2003CA2129626C Acrylic copolymer membranes for biosensors
09/09/2003CA2108282C Quantitative clotting assay for activated factor vii
09/04/2003WO2003073351A2 Screening process
09/04/2003WO2003073350A2 Method and analytical system for identifying targets in a signaling network
09/04/2003WO2003073107A2 Neuropeptide receptor and uses thereof
09/04/2003WO2003073104A2 Diagnostic and therapeutic use of ma onconeuronal antigens for neurodegenerative diseases
09/04/2003WO2003073102A1 Method of diagnosing adolescent idiopathic scoliosis and related syndromes
09/04/2003WO2003073099A1 Method for diagnosing and monitoring hemostatic dysfunction, severe infection and systematic inflammatory response syndrome
09/04/2003WO2003073097A2 Methods for isolating ligands e.g. t cell epitopes
09/04/2003WO2003073096A1 Oligonucleotide-based logic gates and molecular networks
09/04/2003WO2003073088A2 Apparatus and method for the detection of localised fluctuactions of ionic charge by ion sensitive field effect transistors during a chemical reaction
09/04/2003WO2003073068A2 Population based assessments and means to rank the relative immunogenicity of proteins
09/04/2003WO2003073067A2 Rna detection enzymes
09/04/2003WO2003073066A2 Reagents and methods for assaying bacillus anthracis lethal factor protease
09/04/2003WO2003073065A2 Molecular diagnosis and prognosis of carcinomas
09/04/2003WO2003073062A2 Reagents and methods for identifying and modulating expression of genes regulated by cdk inhibitors
09/04/2003WO2003072832A1 Method of error reduction in nucleic acid populations
09/04/2003WO2003072831A1 Surface modification, linker attachment, and polymerization methods
09/04/2003WO2003072829A1 Nanostructures containing pna joining or functional elements
09/04/2003WO2003072828A2 Fcgammariib polymorphisms detection in system lupus erythematosus
09/04/2003WO2003072827A1 Method for diagnosis and treatment of rheumatoid arthritis
09/04/2003WO2003072826A1 Stain-directed molecular analysis for cancer prognosis and diagnosis
09/04/2003WO2003072825A1 Apparatus for automatically analyzing genetic and protein materials using photodiodes
09/04/2003WO2003072824A1 Markers for predicting pathological conditions in haert failure and method of using the same
09/04/2003WO2003072823A2 Method for in vitro detection of cancers by highlighting allelic imbalances in insertion/deletion markers
09/04/2003WO2003072822A2 Mononucleotide repeats microsatellite markers for detecting microsatellite instability.
09/04/2003WO2003072821A2 Method and nucleic acids for the analysis of a colon cell proliferactive disorder
09/04/2003WO2003072820A2 Method and nucleic acids for the analysis of colon cell proliferative disorders
09/04/2003WO2003072819A2 Analysis of mixtures of nucleic acid fragments and of gene expression
09/04/2003WO2003072818A2 Method for sorting single-stranded nucleic acids
09/04/2003WO2003072817A2 Increasing the sensitivity and specificity of nucleic acid chip hybridization tests
09/04/2003WO2003072816A2 Method for modifying the concentration of transcripts in biological samples containing ribonucleic acid
09/04/2003WO2003072815A2 Method for the qualitative and quantitative determination of genetic material
09/04/2003WO2003072814A2 Improved method for allele-specific pcr
09/04/2003WO2003072813A2 Single nucleotide polymorphisms predicting adverse drug reactions and medication efficacy
09/04/2003WO2003072812A2 Method and nucleic acids for the analysis of colorectal cell proliferative disorders
09/04/2003WO2003072811A2 The use of ribozymes in the detection of adventitious agents
09/04/2003WO2003072810A1 Headloop dna amplification
09/04/2003WO2003072809A1 Melting temperature dependent dna amplification
09/04/2003WO2003072808A1 Assay for activity of the actriib kinase
09/04/2003WO2003072807A2 Sterility testing apparatus
09/04/2003WO2003072805A2 Recombinase polymerase amplification
09/04/2003WO2003072804A2 Nanostructures containing pilin protein
09/04/2003WO2003072803A2 Nanostructures containing antibody assembly units
09/04/2003WO2003072801A2 Compositions and method for regulation of calcium-dependent signalling in brain
09/04/2003WO2003072799A2 Brother of the regulator of imprinted sites (boris)
09/04/2003WO2003072798A2 Method for generating amplified rna
09/04/2003WO2003072787A2 Method for detection of leptin receptor ligands
09/04/2003WO2003072779A1 Method of using pituitary-specific genes
09/04/2003WO2003072778A1 Method of examining allergic disease
09/04/2003WO2003072765A1 Process for sorting motile particles from lesser-motile particles and apparatus suitable therefor
09/04/2003WO2003072758A2 Methods for designing oligo-probes with high hybridization efficiency and high antisense activity
09/04/2003WO2003072751A2 Expression system for human brain-specific voltage-gated sodium channel, type 1
09/04/2003WO2003072746A2 Subtilisin carlsberg proteins with reduced immunogenicity
09/04/2003WO2003072740A2 Novel type-1 cytokine receptor glm-r
09/04/2003WO2003072739A2 Trans-splicing mediated imaging of gene expression
09/04/2003WO2003072738A2 Beta chain-associated regulator of apoptosis
09/04/2003WO2003072732A2 Methods of making hypermutable cells using pmsr homologs
09/04/2003WO2003072721A2 Detection by sliding template amplification
09/04/2003WO2003072718A2 In situ induced antigen technology (isiat) for identification of polynucleotides expressed during infection or colonization
09/04/2003WO2003072716A2 Sequence analysis of the tetravalent rotavirus vaccine
09/04/2003WO2003072701A1 A system for analyzing dna-chips using gene ontology and a method thereof
09/04/2003WO2003072700A2 Androgen receptor overexpressing skeletal myoblasts
09/04/2003WO2003072609A1 Tick chitinase
09/04/2003WO2003072595A2 Methods and products based on oligomerization of stress proteins
09/04/2003WO2003072542A2 Interfacial biomaterials
09/04/2003WO2003072256A1 Holding tray having through-hole wells
09/04/2003WO2003072114A1 Vascular therapeutics
09/04/2003WO2003072090A2 Use of tyrosine kinase inhibitors for treating cns disorders
09/04/2003WO2003072065A2 Drug signatures
09/04/2003WO2003072064A2 Methods and compositions for regulating adipogenesis
09/04/2003WO2003072051A2 Methods of using fet labeled oligonucleotides that include a 3' 5' exonuclease resistant quencher domain and compositions for practicing the same
09/04/2003WO2003072045A2 Treatment and prevention of aids progression and methods of using same
09/04/2003WO2003072035A2 Compositions and methods for the treatment of immune related diseases
09/04/2003WO2003072023A2 Novel compositions and methods for the identification, assessment, prevention and therapy of ovarian cancer
09/04/2003WO2003071933A2 Novel compositions and methods for cancer
09/04/2003WO2003071927A2 Diagnostics and therapeutics for macular degeneration-related disorders
09/04/2003WO2003071877A1 Compositions and methods for eliciting an immune response to gram-negative bacterial infections
09/04/2003WO2003071865A2 Molecular markers for identification of fat and lean phenotypes in chickens
09/04/2003WO2003064451A3 MODULATION OF TYPE IIβ PHOSPHOINOSITIDE PHOSPHATE KINASE
09/04/2003WO2003061454A3 Automatically detecting cells having nuclear and cytoplasmic densitometric features associated with disease by optical imaging
09/04/2003WO2003057723A3 Fluorogenic protease substrates doubly labelled with rhodamine moieties
09/04/2003WO2003053224A3 Novel compositions and methods for cancer
09/04/2003WO2003053223A3 Prostate cancer diagnosis and outcome prediction by expression analysis
09/04/2003WO2003051302A3 Methods and compositions for treatment of central nervous system disorders
09/04/2003WO2003048334A3 Immunocytokines with modulated selectivity
09/04/2003WO2003046003A3 Plasma protease c1 biopolymer markers predictive of alzheimers disease
1 ... 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 ... 3003